BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 32640513)

  • 21. Genomics and Precision Medicine: Implications for Critical Care.
    Kessler C
    AACN Adv Crit Care; 2018; 29(1):28-35. PubMed ID: 29496711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomics for disease treatment and prevention.
    Bloss CS; Jeste DV; Schork NJ
    Psychiatr Clin North Am; 2011 Mar; 34(1):147-66. PubMed ID: 21333845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders.
    Raikwar SP; Kikkeri NS; Sakuru R; Saeed D; Zahoor H; Premkumar K; Mentor S; Thangavel R; Dubova I; Ahmed ME; Selvakumar GP; Kempuraj D; Zaheer S; Iyer SS; Zaheer A
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):608-641. PubMed ID: 31011884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory healthcare by design: Computational approaches bringing respiratory precision and personalised medicine closer to bedside.
    Kaul H
    Morphologie; 2019 Dec; 103(343):194-202. PubMed ID: 31711740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision Medicine in the Management of Dilated Cardiomyopathy: JACC State-of-the-Art Review.
    Fatkin D; Huttner IG; Kovacic JC; Seidman JG; Seidman CE
    J Am Coll Cardiol; 2019 Dec; 74(23):2921-2938. PubMed ID: 31806137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "
    Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to Integrate Personalized Medicine into Prevention? Recommendations from the Personalized Prevention of Chronic Diseases (PRECeDI) Consortium.
    Boccia S; Pastorino R; Ricciardi W; Ádány R; Barnhoorn F; Boffetta P; Cornel MC; De Vito C; Gray M; Jani A; Lang M; Roldan J; Rosso A; Sánchez JM; Van Dujin CM; Van El CG; Villari P; Zawati MH
    Public Health Genomics; 2019; 22(5-6):208-214. PubMed ID: 31805565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of Genomic Data in Translational Medicine During the Big Data Era.
    Zhang Y; Yu J; Xie X; Jiang F; Wu C
    Front Biosci (Landmark Ed); 2024 Jan; 29(1):7. PubMed ID: 38287799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Artificial intelligence, physiological genomics, and precision medicine.
    Williams AM; Liu Y; Regner KR; Jotterand F; Liu P; Liang M
    Physiol Genomics; 2018 Apr; 50(4):237-243. PubMed ID: 29373082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy.
    Griñán-Ferré C; Bellver-Sanchis A; Guerrero A; Pallàs M
    Pharmacol Res; 2024 Jul; 205():107247. PubMed ID: 38834164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.
    Qoronfleh MW; Chouchane L; Mifsud B; Al Emadi M; Ismail S
    Life Sci Soc Policy; 2020 Nov; 16(1):12. PubMed ID: 33129349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One step closer to personalized genomic medicine.
    Judge DP
    Eur Heart J; 2010 Sep; 31(18):2194-6. PubMed ID: 20710007
    [No Abstract]   [Full Text] [Related]  

  • 33. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
    Weitzel JN; Blazer KR; MacDonald DJ; Culver JO; Offit K
    CA Cancer J Clin; 2011; 61(5):327-59. PubMed ID: 21858794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omics technologies in personalized combination therapy for cardiovascular diseases: challenges and opportunities.
    Banerjee S; Prabhu Basrur N; Rai PS
    Per Med; 2021 Sep; 18(6):595-611. PubMed ID: 34689602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Personalized medicine--a tailored health care system: challenges and opportunities.
    Louca S
    Croat Med J; 2012 Jun; 53(3):211-3. PubMed ID: 22661133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Operationalizing Precision Cardiovascular Medicine: Three Innovations.
    Wang JJ; Aboulhosn JA; Hofer IS; Mahajan A; Wang Y; Vondriska TM
    Circ Res; 2016 Oct; 119(9):984-987. PubMed ID: 27737942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetics of Early Cardiometabolic Disease: Mechanisms and Precision Medicine.
    Baccarelli AA; Ordovás J
    Circ Res; 2023 Jun; 132(12):1648-1662. PubMed ID: 37289899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology.
    Kirchhof P; Sipido KR; Cowie MR; Eschenhagen T; Fox KA; Katus H; Schroeder S; Schunkert H; Priori S;
    Eur Heart J; 2014 Dec; 35(46):3250-7. PubMed ID: 25148837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring predisposition and treatment response--the promise of genomics.
    Pan S; Knowles JW
    Prog Cardiovasc Dis; 2012; 55(1):56-63. PubMed ID: 22824110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.